Results 31 to 40 of about 362 (162)
Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route
Drug delivery via the oral route has always been challenging for poorly soluble drugs. Acid‐induced hydrolysis, enzymatic degradation, and poor mucosal absorbency remain the primary hiccups for effective oral delivery of medications. With the advent of nanotechnology, nanostructured lipid carriers (NLCs) have emerged as a promising delivery carrier ...
Alok Kumar Mahor +11 more
wiley +1 more source
Towards nanomedicines for neuroAIDS [PDF]
SUMMARYAlthough highly active antiretroviral therapy (HAART) has resulted in remarkable decline in the morbidity and mortality in AIDS patients, controlling HIV infections still remain a global health priority. HIV access to the CNS serves as the natural viral preserve because most antiretroviral (ARV) drugs possess inadequate or zero delivery across ...
Vidya, Sagar +4 more
openaire +2 more sources
Antiretroviral therapy restores the homeostatic state of microglia in SIV‐infected rhesus macaques
Graphical Abstract ScRNA‐seq of rhesus monkey microglia reveals clusters of cells in activated states in the setting of SIV infection, which is primarily reversed by suppressing viremia with combination antiretroviral therapy. Abstract Microglia and macrophages are essential for homeostatic maintenance and innate immune response in the brain.
Andrew J. Trease +6 more
wiley +1 more source
Animal models for studies of HIV‐1 brain reservoirs
Graphical Abstract Review on recent rodent models that contain both human myeloid and T cells for future therapeutics and viral elimination investigations in CNS. Abstract The HIV‐1 often evades a robust antiretroviral‐mediated immune response, leading to persistent infection within anatomically privileged sites including the CNS.
Emiko Waight +8 more
wiley +1 more source
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART
Objective Human immunodeficiency virus (HIV) persistence in blood and tissue reservoirs, including the brain, is a major barrier to HIV cure and possible cause of comorbid disease. However, the size and replication competent nature of the central nervous system (CNS) reservoir is unclear.
Catherine R. Cochrane +18 more
wiley +1 more source
Abstract Osteopontin (OPN) also known by its official gene designation secreted phosphoprotein‐1 (SPP1) is a fascinating, multifunctional protein expressed in a number of cell types that functions not only in intercellular communication, but also in the extracellular matrix (ECM).
Ashley Yim +2 more
wiley +1 more source
NeuroAIDS: An Evolving Epidemic [PDF]
Over 60,000 Canadians are infected with human immunodeficiency virus (HIV). Greater than 50% of these individuals will develop a neurological disorder despite the availability of highly active antiretroviral therapy. HIV causes nervous system disease at all stages of infection with adverse effects on quality of life, adherence to medications ...
Christopher, Power +3 more
openaire +2 more sources
Abstract Astrocyte reactivity, a phenomenon observed in a variety of neurodegenerative disorders, can have both beneficial and detrimental manifestations which significantly affect neuronal physiology. In neuroAIDS, reactive astrocytes have been observed to severely affect the neuronal population present in their vicinity.
Hriday Shanker Pandey +3 more
wiley +1 more source
Mitochondrial quality control in stroke: From the mechanisms to therapeutic potentials
Abstract Mitochondrial damage is a critical contributor to stroke‐induced injury, and mitochondrial quality control (MQC) is the cornerstone of restoring mitochondrial homeostasis and plays an indispensable role in alleviating pathological process of stroke.
Heyan Tian +6 more
wiley +1 more source
Herbs and Rehabilitation after Stroke Study: A Multi-center, Double-blinded, Randomized Trial in Hong Kong [PDF]
published_or_final_versio
Chang, CM +17 more
core +1 more source

